Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis

Abstract

BackgroundExosomes are thought to play an important role in exchanging information between cells. The proteins and lipids in exosomes play roles in mediating inflammatory and autoimmune diseases. The aim of this study was to identify exosomal candidate proteins that are related to other inflammatory parameters in rheumatoid arthritis (RA).MethodsThe study population consisted of 60 patients with RA: 30 in the clinical remission (CR) group with a Disease Activity Score in 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) ≤2.6 and 30 in the non-clinical remission (non-CR) group with a DAS28-ESR >2.6. Preparation of exosomes from patient serum samples was performed with the ExoQuick kit, and protein identification/quantification was performed using tandem mass tag labeling/mass spectrometry and an enzyme-linked immunosorbent assay. Comparisons between groups were made using Student’s t test or the Mann-Whitney U test, as appropriate. Spearman’s correlation coefficients (ρ) were calculated.ResultsWe identified six candidate proteins. Exosomal levels of amyloid A (AA) and lymphatic vessel endothelial hyaluronic acid receptor-1 (LYVE-1) differed between the CR and non-CR groups. Both serum and exosomal AA levels were higher in the non-CR group than in the CR group (p = 0.001). Significant positive correlations were found between exosomal AA and C-reactive protein (CRP) as well as between serum AA and CRP (ρ = 0.614, p = 0.001, and ρ = 0.624, p = 0.001, respectively). Although serum levels of LYVE-1 did not differ between the non-CR and CR groups, exosomal levels of LYVE-1 were lower in the non-CR group than in the CR group (p = 0.01). We identified positive correlations between serum/exosomal LYVE-1 and CRP only in the non-CR group (serum ρ = 0.376, p = 0.04; exosome ρ = 0.545, p = 0.002).ConclusionsExosomal LYVE-1 shows potential for use as an additional marker of disease activity in patients with RA, and exosomes may carry other useful markers for RA.

Identification of differentially expressed circulating exosomal lncRNAs in IgA nephropathy patients

“…Exosomes are known to encapsulate certain proteins, lipids, and RNA, and mediate intercellular communication between various types of cells [15]. Increasing researches are showing that not only can exosomes be diagnostic and prognostic markers for various kinds of malignancies [16], but they also play an important role in immunoregulation and the pathogenesis of immune related diseases such as rheumatoid arthritis (RA) [17], systemic lupus erythematosus (SLE) [18] and IgAN [19]. Exosomes could act as a protective barrier that can protect lncRNAs from extracellular degradation [14,15], hence could be used as an excellent biomarker to detect significant changes in lncRNA profile in IgAN patients.…”

Role of mesenchymal stem cell derived extracellular vesicles in autoimmunity: A systematic review

“…Besides, exosomes-encapsulated miR-155 and miR-146a produced by DCs can serve as important regulators in immune response and inflammatory response in RA[ 85 - 87 ]. It has been shown that the expression of exosomal amyloid A is positively correlated with anti-CCP antibody and CRP, suggesting a vital role of exosomal protein in predicating the disease activity of RA patients[ 88 ]. Taken together, exosomal ncRNAs play critical roles in regulating immune and inflammatory cells and thus participate in the occurrence and development of RA.…”

Extracellular vesicles: A new therapeutic strategy for joint conditions

“…Other reports indicate that serum EVs may be useful as additional markers of disease activity in patients with RA. For instance, differences in EV levels of amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 have been found between the clinical remission and non-clinical remission groups [190]. In addition, high expression of Hotair has been demonstrated in blood mononuclear cells and serum EVs of RA patients whereas a lower level of Hotair was detected in differentiated osteoclasts and rheumatoid synoviocytes [191].…”